Login Register Cart 0
Generic placeholder image

Current Neurovascular Research

Editor-in-Chief

ISSN (Print): 1567-2026
ISSN (Online): 1875-5739

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Impact of HbA1C (Glycated Hemoglobin) and Glucose on Outcomes of Mechanical Thrombectomy in Patients with Large Artery Occlusion

Author(s): Jin G. Kim, Ho J. Yi*, Dong H. Lee and Jae H. Sung

Volume 17, Issue 4, 2020

Page: [376 - 384] Pages: 9

DOI: 10.2174/1567202617666200514115446

Price: $65

Abstract

Objective: This study evaluated the relationship between HbA1c (glycated hemoglobin), admission serum glucose levels and outcomes in patients with large artery occlusion (LAO) treated with mechanical thrombectomy (MT).

Methods: A total of 413 patients were enrolled, and the following outcomes were reviewed: successful recanalization, symptomatic hemorrhage, favorable outcome (modified Rankin Scale, mRS scores of 0-2), and mortality at 3 months. Receiver operating characteristic (ROC) curve analysis was undertaken to identify the cutoff values for HbA1C and glucose to discriminate between favorable and unfavorable outcomes. The association of HbA1c and glucose levels with outcomes was evaluated using logistic regression.

Results: The best cutoff values to discriminate between favorable and unfavorable outcome after 3 months were identified by an HbA1C value of 6.0% and an admission serum glucose level of 131 mg/dL (P = <0.001 and <0.001, respectively). Patients with HbA1C ≥6.0% had a lower ratio of favorable mRS, more symptomatic hemorrhage, and higher mortality than those of HbA1C <6.0% (P = 0.002, 0.001, and <0.001, respectively). In multivariate analysis, high HbA1C (≥6.0%) and serum glucose on admission (≥131 mg/dL) were significantly associated with unfavorable outcomes at 3 months (P = 0.006 and 0.009, respectively).

Conclusion: This study demonstrated that patients with HbA1C ≥6.0% had more unfavorable 3- month mRS, higher symptomatic hemorrhage, and a higher degree of mortality than those with HbA1C <6.0%. Higher HbA1C and admission serum glucose levels are independent predictors of unfavorable clinical outcomes in LAO patients treated with MT.

Keywords: Glucose, glycated hemoglobin, hyperglycemia, ischemic stroke, thrombectomy thrombolysis, mitochondrial dysfunction.

« Previous Next »
[1]
Quinn TJ, Lees KR. Hyperglycaemia in acute stroke--to treat or not to treat. Cerebrovasc Dis 2009; 27(Suppl. 1): 148-55.
[http://dx.doi.org/10.1159/000200453] [PMID: 19342845]
[2]
Kruyt ND, Biessels GJ, Devries JH, Roos YB. Hyperglycemia in acute ischemic stroke: Pathophysiology and clinical management. Nat Rev Neurol 2010; 6(3): 145-55.
[http://dx.doi.org/10.1038/nrneurol.2009.231] [PMID: 20157308]
[3]
Yong M, Kaste M. Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial. Stroke 2008; 39(10): 2749-55.
[http://dx.doi.org/10.1161/STROKEAHA.108.514307] [PMID: 18703813]
[4]
Alvarez-Sabín J, Molina CA, Montaner J, et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients. Stroke 2003; 34(5): 1235-41.
[http://dx.doi.org/10.1161/01.STR.0000068406.30514.31] [PMID: 12677014]
[5]
De Silva DA, Ebinger M, Christensen S, et al. Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators. Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial. Cerebrovasc Dis 2010; 29(1): 14-21.
[http://dx.doi.org/10.1159/000255969] [PMID: 19893307]
[6]
Tanne D, Kasner SE, Demchuk AM, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: The Multicenter rt-PA Stroke Survey. Circulation 2002; 105(14): 1679-85.
[http://dx.doi.org/10.1161/01.CIR.0000012747.53592.6A] [PMID: 11940547]
[7]
Goyal N, Tsivgoulis G, Pandhi A, et al. Admission hyperglycemia and outcomes in large vessel occlusion strokes treated with mechanical thrombectomy. J Neurointerv Surg 2018; 10(2): 112-7.
[http://dx.doi.org/10.1136/neurintsurg-2017-012993] [PMID: 28289148]
[8]
Wang L, Zhou Z, Tian X, et al. ACTUAL investigators. Impact of relative blood glucose changes on mortality risk of patient with acute ischemic stroke and treated with mechanical thrombectomy. J Stroke Cerebrovasc Dis 2019; 28(1): 213-9.
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2018.09.036] [PMID: 30539756]
[9]
Choi KH, Kim JH, Kang KW, et al. HbA1c (glycated hemoglobin) levels and clinical outcome post-mechanical thrombectomy in patients with large vessel occlusion. Stroke 2018; 50(1): 119-26.
[10]
Diprose WK, Wang MTM, McFetridge A, Sutcliffe J, Barber PA. Glycated hemoglobin (HbA1c) and outcome following endovascular thrombectomy for ischemic stroke. J Neurointerv Surg 2020; 12(1): 30-2.
[http://dx.doi.org/10.1136/neurintsurg-2019-015023] [PMID: 31147437]
[11]
Kim JT, Jahan R, Saver JL, Investigators S. SWIFT Investigators. Impact of glucose on outcomes in patients treated with mechanical thrombectomy: A post hoc analysis of the solitaire flow restoration with the intention for thrombectomy study. Stroke 2016; 47(1): 120-7.
[http://dx.doi.org/10.1161/STROKEAHA.115.010753] [PMID: 26658447]
[12]
Anderson RE, Tan WK, Martin HS, Meyer FB. Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke 1999; 30(1): 160-70.
[http://dx.doi.org/10.1161/01.STR.30.1.160] [PMID: 9880405]
[13]
Suh SW, Shin BS, Ma H, et al. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann Neurol 2008; 64(6): 654-63.
[http://dx.doi.org/10.1002/ana.21511] [PMID: 19107988]
[14]
Luitse MJ, Biessels GJ, Rutten GE, Kappelle LJ. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol 2012; 11(3): 261-71.
[http://dx.doi.org/10.1016/S1474-4422(12)70005-4] [PMID: 22341034]
[15]
Desilles JP, Syvannarath V, Ollivier V, et al. Exacerbation of thromboinflammation by hyperglycemia precipitates cerebral infarct growth and hemorrhagic transformation. Stroke 2017; 48(7): 1932-40.
[http://dx.doi.org/10.1161/STROKEAHA.117.017080] [PMID: 28526762]
[16]
Martini SR, Kent TA. Hyperglycemia in acute ischemic stroke: A vascular perspective. J Cereb Blood Flow Metab 2007; 27(3): 435-51.
[http://dx.doi.org/10.1038/sj.jcbfm.9600355] [PMID: 16804552]
[17]
Shukla V, Shakya AK, Perez-Pinzon MA, Dave KR. Cerebral ischemic damage in diabetes: An inflammatory perspective. J Neuroinflammation 2017; 14(1): 21.
[http://dx.doi.org/10.1186/s12974-016-0774-5] [PMID: 28115020]
[18]
Garg R, Chaudhuri A, Munschauer F, Dandona P. Hyperglycemia, insulin, and acute ischemic stroke: A mechanistic justification for a trial of insulin infusion therapy. Stroke 2006; 37(1): 267-73.
[http://dx.doi.org/10.1161/01.STR.0000195175.29487.30] [PMID: 16306459]
[19]
Masrur S, Cox M, Bhatt DL, et al. Association of acute and chronic hyperglycemia with acute ischemic stroke outcomes post-thrombolysis: Findings from get with the guidelines-stroke. J Am Heart Assoc 2015; 4(10)e002193
[http://dx.doi.org/10.1161/JAHA.115.002193] [PMID: 26408015]
[20]
Rocco A, Heuschmann PU, Schellinger PD, et al. Glycosylated hemoglobin A1 predicts risk for symptomatic hemorrhage after thrombolysis for acute stroke. Stroke 2013; 44(8): 2134-8.
[http://dx.doi.org/10.1161/STROKEAHA.111.675918] [PMID: 23715962]
[21]
Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. A1C-derived average glucose study group. translating the A1C assay into estimated average glucose values. Diabetes Care 2008; 31(8): 1473-8.
[http://dx.doi.org/10.2337/dc08-0545] [PMID: 18540046]
[22]
Lyons TJ, Basu A. Biomarkers in diabetes: Hemoglobin A1C, vascular and tissue markers. Transl Res 2012; 159(4): 303-12.
[http://dx.doi.org/10.1016/j.trsl.2012.01.009] [PMID: 22424433]
[23]
Hacke W, Kaste M, Bluhmki E, et al. ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359(13): 1317-29.
[http://dx.doi.org/10.1056/NEJMoa0804656] [PMID: 18815396]
[24]
Deshaies EM. Tri-axial system using the Solitaire-FR and Penumbra Aspiration Microcatheter for acute mechanical thrombectomy. J Clin Neurosci 2013; 20(9): 1303-5.
[http://dx.doi.org/10.1016/j.jocn.2012.10.037] [PMID: 23835465]
[25]
Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. Classification of stroke subtypes. Cerebrovasc Dis 2009; 27(5): 493-501.
[http://dx.doi.org/10.1159/000210432] [PMID: 19342825]
[26]
American Diabetes Association. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2018. Diabetes Care 2018; 41(Suppl. 1): S13-27.
[http://dx.doi.org/10.2337/dc18-S002] [PMID: 29222373]
[27]
Qiu C, Cotch MF, Sigurdsson S, et al. Retinal and cerebral microvascular signs and diabetes: The age, gene/environment susceptibility-Reykjavik study. Diabetes 2008; 57(6): 1645-50.
[http://dx.doi.org/10.2337/db07-1455] [PMID: 18332097]
[28]
Baker ML, Hand PJ, Wong TY, et al. Multi-Centre Retinal Stroke Study Group. Retinopathy and lobar intracerebral hemorrhage: insights into pathogenesis. Arch Neurol 2010; 67(10): 1224-30.
[http://dx.doi.org/10.1001/archneurol.2010.249] [PMID: 20937950]
[29]
Putaala J, Sairanen T, Meretoja A, et al. Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke. Cerebrovasc Dis 2011; 31(1): 83-92.
[http://dx.doi.org/10.1159/000321332] [PMID: 21079397]
[30]
McCormick M, Hadley D, McLean JR, Macfarlane JA, Condon B, Muir KW. Randomized, controlled trial of insulin for acute poststroke hyperglycemia. Ann Neurol 2010; 67(5): 570-8.
[PMID: 20437554]

Rights & Permissions Print Cite
Article Metrics
47
1
© 2024 Bentham Science Publishers | Privacy Policy